Although we did not have whole-genome sequencing data and, thus, could not discriminate between somatic and rare germline variants found in our samples, we were able to correctly identify colorectal carcinoma samples with the most pronounced hypermutator phenotypes, specifically, MSI-positive and POLE mutation-positive cases. This evidence concerns the gene POLE and colorectal carcinoma.